Neuland Laboratories Rapporto di pagamento

Cos'è Rapporto di pagamento di Neuland Laboratories?

Rapporto di pagamento di Neuland Laboratories Limited è 71.63%

Qual è la definizione di Rapporto di pagamento?



Il payout ratio è la frazione di guadagni pagati in dividendi agli azionisti.

The payout ratio is calculated by dividing the dividends paid out by the net earnings for a certain period. It is usually expressed as a percentage. The part of the earnings not paid to investors is left for investment to provide for future earnings growth. Investors seeking high current income and limited capital growth prefer companies with high payout ratio. However investors seeking capital growth may prefer lower payout ratio because capital gains are taxed at a lower rate. High growth firms in early life generally have low or zero payout ratios. As they mature, they tend to return more of the earnings back to investors.

Rapporto di pagamento di aziende nel Health Care settore su BSE rispetto a Neuland Laboratories

Cosa fa Neuland Laboratories?

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.

Aziende con rapporto di pagamento simili a Neuland Laboratories